{
  "question_stem": {
    "en": "A 21-year-old woman comes to the office due to burning on urination and increased urinary frequency for the past 2 days. She has no hematuria, vaginal discharge, or irritation. The patient has no other medical problems. Her temperature is 37 C (98.6 F). Physical examination reveals mild suprapubic tenderness on deep palpation; there is no costovertebral angle tenderness. Urine dipstick is positive for leukocyte esterase and nitrites. The patient is started on trimethoprim, which leads to rapid resolution of her symptoms.",
    "zh": "一名21岁的女性因过去2天出现排尿灼热感和尿频来就诊。她没有血尿、阴道分泌物或刺激感。该患者没有其他医疗问题。她的体温为37°C（98.6°F）。体格检查显示深部触诊时轻度耻骨上压痛；没有肋椎角压痛。尿液试纸对白细胞酯酶和亚硝酸盐呈阳性。该患者开始服用甲氧苄氨嘧啶，这导致她的症状迅速缓解。"
  },
  "question": {
    "en": "Which of the following medications has the same intracellular target as the drug used to treat this patient?",
    "zh": "以下哪种药物与用于治疗该患者的药物具有相同的细胞内靶点？"
  },
  "options": {
    "A": {
      "en": "Bacitracin",
      "zh": "杆菌肽"
    },
    "B": {
      "en": "Imipenem",
      "zh": "亚胺培南"
    },
    "C": {
      "en": "Methotrexate",
      "zh": "甲氨蝶呤"
    },
    "D": {
      "en": "Metronidazole",
      "zh": "甲硝唑"
    },
    "E": {
      "en": "Sulfamethoxazole",
      "zh": "磺胺甲恶唑"
    }
  },
  "correct_answer": "C",
  "explanation": {
    "en": "Trimethoprim (in bacteria), methotrexate (in human cells), and pyrimethamine (in some protozoa) all prevent the reduction of folic acid to tetrahydrofolate (THF) by inhibiting dihydrofolate reductase (DHFR). Trimethoprim restricts bacterial growth through this process and works particularly well in conjunction with sulfonamides (eg, sulfamethoxazole), which inhibit an earlier step in the bacterial folic acid pathway (see Choice E); the combination of trimethoprim and sulfamethoxazole produces a \"sequential blockade.\"\n\nMethotrexate is a folate antimetabolite that targets rapidly proliferating human cells by halting DNA synthesis through binding DHFR. Methotrexate is cell-cycle specific for the S phase as it prevents synthesis of purines and thymine. Pyrimethamine is effective for treatment of malaria and toxoplasmosis because it inhibits parasitic DHFR.\n\n(Choice A) Bacitracin prevents mucopeptide transfer into the growing cell wall, thereby inhibiting bacterial cell wall synthesis.\n\n(Choice B) Imipenem binds to penicillin binding proteins, thereby inhibiting the final step of peptidoglycan synthesis (crosslinking) in bacterial cell walls. It is administered in combination with cilastatin, which prevents renal metabolism of imipenem by competitively inhibiting dehydropeptidase on the renal tubule brush border.\n\n(Choice D) Metronidazole forms cytotoxic intermediates (eg, nitroso radicals) within anaerobic organisms that interact with DNA, disrupting the helical structure and breaking its strands. RNA transcription and protein synthesis are inhibited, and the cell dies soon thereafter.\n\n(Choice E) As a structural analog of para-aminobenzoic acid (PABA), sulfamethoxazole competes with PABA to inhibit dihydropteroate synthetase, one of the enzymes needed for dihydrofolic acid synthesis. This is an intermediate step in the formation of THF.\n\nEducational objective:\nTrimethoprim, methotrexate, and pyrimethamine inhibit dihydrofolate reductase. Trimethoprim restricts bacterial growth through this process, and works particularly well in conjunction with sulfonamide, which inhibits an earlier step in the bacterial folic acid pathway.",
    "zh": "甲氧苄氨嘧啶（在细菌中）、甲氨蝶呤（在人体细胞中）和乙胺嘧啶（在某些原生动物中）均通过抑制二氢叶酸还原酶（DHFR）来阻止叶酸还原为四氢叶酸（THF）。甲氧苄氨嘧啶通过此过程限制细菌生长，并且与磺胺类药物（如磺胺甲恶唑）联合使用效果特别好，磺胺类药物可抑制细菌叶酸途径的早期步骤（见选项E）；甲氧苄氨嘧啶和磺胺甲恶唑的组合产生“顺序阻滞”。\n\n甲氨蝶呤是一种叶酸代谢抑制剂，通过与DHFR结合来抑制DNA合成，从而靶向快速增殖的人体细胞。甲氨蝶呤是细胞周期特异性的，作用于S期，因为它阻止了嘌呤和胸腺嘧啶的合成。乙胺嘧啶对治疗疟疾和弓形虫病有效，因为它抑制寄生虫DHFR。\n\n（选项A）杆菌肽阻止粘肽转移到生长的细胞壁中，从而抑制细菌细胞壁合成。\n\n（选项B）亚胺培南与青霉素结合蛋白结合，从而抑制细菌细胞壁中肽聚糖合成（交联）的最后一步。它与西司他丁联合给药，西司他丁通过竞争性抑制肾小管刷状缘上的脱氢肽酶来阻止亚胺培南的肾脏代谢。\n\n（选项D）甲硝唑在厌氧生物体内形成细胞毒性中间体（如亚硝基自由基），这些中间体与DNA相互作用，破坏螺旋结构并断裂其链。RNA转录和蛋白质合成受到抑制，细胞很快死亡。\n\n（选项E）作为对氨基苯甲酸（PABA）的结构类似物，磺胺甲恶唑与PABA竞争，抑制二氢蝶酸合酶，这是二氢叶酸合成所需的酶之一。这是THF形成的一个中间步骤。\n\n教育目标：\n甲氧苄氨嘧啶、甲氨蝶呤和乙胺嘧啶抑制二氢叶酸还原酶。甲氧苄氨嘧啶通过此过程限制细菌生长，并且与磺胺类药物联合使用效果特别好，磺胺类药物可抑制细菌叶酸途径的早期步骤。"
  },
  "summary": {
    "en": "This question tests knowledge of the mechanism of action of trimethoprim and other drugs that target folate metabolism. Specifically, it asks about the intracellular target of trimethoprim, which is dihydrofolate reductase (DHFR).\n\nTo solve this question, recall that trimethoprim inhibits DHFR in bacteria, methotrexate inhibits DHFR in human cells, and pyrimethamine inhibits DHFR in protozoa. Therefore, the medication with the same intracellular target as trimethoprim is methotrexate.",
    "zh": "这个问题测试对甲氧苄氨嘧啶和其他靶向叶酸代谢的药物的作用机制的了解。具体来说，它询问了甲氧苄氨嘧啶的细胞内靶点，即二氢叶酸还原酶（DHFR）。\n\n要解决这个问题，请记住甲氧苄氨嘧啶在细菌中抑制DHFR，甲氨蝶呤在人体细胞中抑制DHFR，乙胺嘧啶在原生动物中抑制DHFR。因此，与甲氧苄氨嘧啶具有相同细胞内靶点的药物是甲氨蝶呤。"
  },
  "tags": "Trimethoprim; Methotrexate; Dihydrofolate reductase; Folate metabolism; Antibiotics; Antimetabolites; Infectious diseases; Pharmacology",
  "category": "Micro",
  "question_id": "1104",
  "has_exhibits": false,
  "exhibit_count": 0,
  "exhibit_files": [],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\Micro 23\\1104",
  "extracted_at": "2025-11-05T14:50:01.721370",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 1,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T18:05:06.758201",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}